Skip to content

Grouptraining for Overactive Bladder in Adults

A Clinical, Randomized, Comparative, Non-blinded Study on the Effect of Bladdertraining in Groups Compared to Individual Bladdertraining for Female Patients With Overactive Bladder.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01187082
Enrollment
91
Registered
2010-08-23
Start date
2009-12-31
Completion date
2013-03-31
Last updated
2015-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive Bladder

Keywords

overactive bladder, women, bladder training, groups

Brief summary

Hypothesis:the effect of bladdertraining in groups for patients with OAB (overactive bladder syndrome) equals the effect of bladdertraining individually for patients with overactive bladder. The effect of the training is measured in a 3 dimensional scope by the means of 3 primary outcome measures used in the statistical evaluation. Symptoms of OAB (either (1)urgencyepisodes or (2)urgencyincontinence) and (3)quality of life (VAS score).

Detailed description

Program consisting of 3 hourly sessions with bladdertraining and daily training with a pocket bladder schedule. patients are randomised either for groups or individual training with a continence nurse over a period of 2 months.

Interventions

BEHAVIORALbladdertraining in groups

Cognitive training in groups of 4 patients at hospital by a continence nurse in 3 sessions (1 hour)over a period of 1 month. Follow up after 1 month. During all 2 month the patient has selfinitiatied daily training with a pocket bladder schedule.

BEHAVIORALbladdertraining individually

Cognitive training individually at hospital by a continence nurse in 3 sessions (1 hour)over a period of 1 month. Follow up after 1 month. During all 2 month the patient has selfinitiatied daily training with a pocket bladder schedule.

Sponsors

University of Aarhus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* women at the age of 18 and more * patients with overactive bladder

Exclusion criteria

* dominance of stress incontinence * not able to attend sessions * do not to understand danish * do not want training in groups or individual * hormonebalanced (if postmenopausal with added hormonetreatment for at least 2 months) * no treatment for OAB up till 1 month before study and during study * no renal or neurological diseases, symptomatic cystitis or non regulated diabetes * no pregnancy during study * no normal gynecological examination * no operation in pelvis up till 3 month before studystart * no polyuria measured 2 times before studystart (\> 40 ml/ kg/ day) * no upstart of treatment with medication during studystart which according to the investigator can create symptoms of OAB * no participation in other CT

Design outcomes

Primary

MeasureTime frameDescription
urgencyepisodesafter 2 month (end of study)with a bladderdiary episodes are counted at studystart / after 3 sessions of training and after 2 month (studyend)
urgeincontinenceafter 2 month (studyend)with a bladderdiary episodes are counted at studystart / after 3 sessions of training and after 2 month (studyend)
VAS score from ICI_OAB_Qafter 2 month (studyend)with the ICI\_OAB\_Q counted before studystart / after 3 sessions/ after 2 month (studyend)

Secondary

MeasureTime frameDescription
voiding frequencyafter 2 month (studyend)counted from a bladder diary before studystart/ after 3 sessions of training/ after 2 month (studyend)
Compliance in trainingafter 2 month (studyend)counted from a pocket bladder schedule at every training session (3 times)and after 2 month (studyend)
Adverse eventsafter 2 month (studyend)asked at every training session (3 times)and after 2 month (studyend). Patients are supposed to report in if any AEs during study

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026